LinkedInXFacebook
Subscribe
Orthopedics This Week
  • My Feed
  • |Posts
  • |Events
  • |MSK Innovations
  • |Power Rankings
  • |Masterclasses
  • |Technology Awards
  • Press Releases
  • |Advertising
  • |Job Board
  • Spine
  • ◆Joints
  • ◆Upper Extremities
  • ◆Foot & Ankle
  • ◆Sports Medicine
  • ◆Pain Mgmt
  • ◆Trauma
  • ◆Biologics
  • ◆Technology
  • ◆People
  • ◆Company News
  • ◆Legal & Regulatory
Home/People In The News/Britain’s Keith Jackson Named Top Corporate Director
People In The News

Britain’s Keith Jackson Named Top Corporate Director

November 4, 2016 1 min read Premium comments

Advertisement

Britain’s Keith Jackson Named Top Corporate Director
Keith Jackson

Keith Jackson, the chief executive of Sheffield healthcare company JRI Orthopaedics, has been named the UK’s top Mid-Market company director.

The company, JRI Orthopaedic, is Britain’s largest orthopedic manufacturer, wholly owned by the charity Orthopaedic Research UK (ORUK). It has donated £12m over the last 10 years to fund research into bone and joint disease at centers of excellence across the country.

Upon receiving the award, Jackson said: “I am absolutely delighted to receive this award from the Institute of Directors. My inspiration comes from the thousands upon thousands of patients who benefit from the transforming implants that JRI Orthopaedics precision manufactures here in the UK. It is truly an honor to run such a fantastic British company.”

After graduating from the University of Leeds with a degree in mechanical engineering, Professor Jackson spent the first five years of his career as a design engineer for car manufacturer Jaguar. After a year of voluntary work in Africa, he returned to the UK to achieve an MSc in biomedical engineering.

A Chartered Mechanical Engineer and a Fellow of both the IMechE and the Institute of Directors, Professor Jackson worked in sales, product development and management at JRI Orthopaedics before becoming Chief Executive in 2010.

In 2015, he was appointed as the IoD’s branch chairman for South Yorkshire and this month also took up the position of Visiting Professor at the University of Sheffield’s Department of Materials Science and Engineering.

React:

Discussion

14
DS
Dr. Sarah MitchellOrthopedic Surgeon · Mayo Clinic

This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?

8
JT
James Thornton, MDSpine Fellow · HSS

Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.

5
RP
R. PatelSports Medicine · Stanford

We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.

Join the conversation

Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.

Subscribe

Get Full Access

Read every OTW article and join member discussions for $24.99/month.

Get Full Access

Advertisement

Advertisement

Advertisement

Orthopedics This Week

The most trusted source in orthopedic industry news since 2005. Covering spine, joints, trauma, biologics, and the business of orthopedics.

A publication of RRY Publications, LLC

LinkedInXFacebook

Categories

  • Spine
  • Joints
  • Upper Extremities
  • Foot & Ankle
  • Sports Medicine
  • Pain Mgmt
  • Trauma
  • Biologics
  • Technology
  • People
  • Company News
  • Legal & Regulatory

Resources

  • Subscribe
  • Community Posts
  • Job Board
  • Press Release Opportunities
  • Power Rankings
  • About OTW
  • Advertise
  • Contact Us

Get Full Access

Unlimited articles, community posts, and Power Rankings.

Get Full Access

Plans start at $24.99/mo · Annual saves 20%

© 2026 Orthopedics This Week · RRY Publications, LLC

Privacy PolicyTerms of ServiceCookie Policy